[Influenza. Study of recent acquisitions. Prevention and therapy]
Related Experiment Video
Updated: Oct 23, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Abstract:
Experience in the field of influenza (vaccination, chemical prevention, clinical pictures, treatment) during the period 1964-1974 is briefly described. The possibility that certain gastroenteric syndromes may suitably be labelled as"influenza" is examined. The usefulness of EAI antibody determination in "a posteriori" differential diagnosis of certain clinical forms, the assessment of the value of vaccination, and for mediocolegal purposes is asserted. It is suggested, in the light of personal experience, that vaccination with virus strains involved at the outset of an epidemic will only be useful where the antibody response to such strains is equal to more than 1:80. The chemical prevention of the disease is briefly examined,though the view that it is only effective in special cases is maintained.
More Related Videos
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
05:21A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management
Influenza
Respiratory Syncytial Virus Disease
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release